Skip to content

Letrozole Versus Laparoscopic Ovarian Drilling in Polycystic Ovary Syndrome

Letrozole Versus Laparoscopic Ovarian Drilling for Clomiphene-resistant Women With Polycystic Ovary Syndrome

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03009838
Enrollment
150
Registered
2017-01-04
Start date
2017-01-02
Completion date
2023-08-31
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

Polycystic ovary syndrome is the major cause of anovulatory infertility. Clomiphene citrate is the most commonly used oral agent for ovulation induction in this group, but there are some drawbacks with the use of it.

Interventions

DRUGLetrozole

oral tablets 2.5 mg

laparoscopic electrocauterization

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* History of at least one year of infertility either primary or secondary. * Body mass index: 25-35 * Normal fallopian tubes * Normal semen analysis of the husband * Women who will accept to participate in the study

Exclusion criteria

* Body mass index above 35 * Contraindication to general anesthesia * Previous laparoscopic drilling * Presence of other causes of infertility * Women who had received metformin, gonadotrophin, oral contraceptives or other hormonal drugs during the preceding 6 months * Women who intended to start a diet program * Women who will refuse to participate in the study.

Design outcomes

Primary

MeasureTime frame
The ovulation rate3 months

Secondary

MeasureTime frame
The mid-cyclic endometrial thicknessone day

Countries

Egypt

Contacts

Primary ContactAhmed Abbas, MD
bmr90@hotmail.com00201003385183

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026